Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Public ClinicalTrials.gov record NCT01846793. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-8 Years Apart
Study identification
- NCT ID
- NCT01846793
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Nymox Corporation
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Interventions
- NX-1207 Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2013
- Primary completion
- Sep 30, 2014
- Completion
- Sep 30, 2014
- Last update posted
- Mar 9, 2017
2013 – 2014
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Laguna Beach | California | 92653 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | San Diego | California | 92120 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Aventura | Florida | 33180 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Naples | Florida | 34102 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Meridian | Idaho | 83642 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Jeffersonville | Indiana | 47130 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Shreveport | Louisiana | 71106 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Annapolis | Maryland | 21401 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Baltimore | Maryland | 21237 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Glen Burnie | Maryland | 21061 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Towson | Maryland | 21204 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Missoula | Montana | 59808 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Brick | New Jersey | 08724 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Garden City | New York | 11530 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New York | New York | 10016 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Columbus | Ohio | 43221 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Dallas | Texas | 75010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01846793, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01846793 live on ClinicalTrials.gov.